This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Microcap Article: Archive
UAVS Stock Dips as Q3 Loss Narrows Y/Y, Defense Pipeline Grows
by Zacks Equity Research
AgEagle's stock tumbles after Q3 results show weaker revenues, rising costs and growing reliance on financing despite momentum in defense and sensor markets.
UAVSPositive Net Change
consumer-staples earnings
FKWL Stock Declines 12.4%, Q1 Profit Strengthens Amid Lower Sales
by Zacks Equity Research
Franklin Wireless shares slide after Q1 results show lower sales but stronger margins and higher profit, highlighting shifting demand and cost efficiencies.
FKWLNegative Net Change
earnings tech-stocks
MITQ's Q1 Earnings Up Y/Y, Eyes Growth via DCS Audio Expansion
by Zacks Equity Research
MiT posts improved margins and a swing to profitability in fiscal Q1. The DCS speaker line acquisition is now a key growth driver as the firm pushes into global cinema audio markets.
MITQPositive Net Change
business-services earnings
RVP Stock Rises Post Q3 Earnings Despite Tariff and Cost Pressures
by Zacks Equity Research
Retractable Technologies reports improved third-quarter 2025 earnings driven by better margins, investment gains and a shift toward domestic production.
RVPNegative Net Change
earnings medical medical-devices
Maui Land & Pineapple Posts Wider Net Loss in Q3, Revenues Grow
by Zacks Equity Research
MLP saw stronger leasing and land sales in Q3, but pension costs widened losses as investors reacted with a sharp post-earnings selloff.
MLPPositive Net Change
earnings finance
Blue Dolphin Shares Sink as Q3 Loss Widens, Debt & ARO Costs Mount
by Zacks Equity Research
BDCO's stock slumps after Q3 results show falling revenue, narrower losses and rising regulatory and debt pressures weighing on future performance.
BDCONegative Net Change
earnings energy oil-energy
ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin Strength
by Zacks Equity Research
ImmuCell tumbles despite stronger margins and a rebound in EPS, as backlog dynamics pressure quarterly sales while management highlights improving operations.
ICCCPositive Net Change
earnings medical
OPTX Incurs Q3 Loss Due to High Labor Costs, Stock Down 31%
by Zacks Equity Research
Syntec Optics' Q3 results grapple with rising labor and overhead costs, audit fees, and cash constraints. Despite these pressures, the company projects stronger Q4 revenues from key growth sectors.
OPTXNegative Net Change
business-services earnings
Fossil Stock Sinks 18% as Q3 Loss Widens Y/Y Amid DTC Weakness
by Zacks Equity Research
FOSL's Q3 loss widens year over year, pressured by direct-to-consumer weakness and store closures, while management reaffirmed full-year guidance and completed a key balance sheet restructuring.
FOSLPositive Net Change
earnings retail
Comstock's Q3 Earnings Decrease Y/Y on ParkX Expansion Costs
by Zacks Equity Research
CHCI's Q3 earnings fall year over year due to higher ParkX expansion costs, despite a rise in revenues and continued growth in recurring fee-based income.
CHCIPositive Net Change
construction earnings
ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance
by Zacks Equity Research
Elite Pharmaceuticals delivers record second-quarter fiscal 2026 earnings as lisdexamfetamine sales surged, though margins faced competitive pressure.
ELTPNegative Net Change
earnings medical
Vaso Stock Up Following Strong Q3 Earnings and Profit Turnaround
by Zacks Equity Research
VASO reports a third-quarter 2025 profit turnaround with higher revenue, stronger margins and robust cash flow from subscriptions.
VASONegative Net Change
earnings medical medical-devices
Precipio Stock Up Following Solid Q3 Earnings and Improved Cash Flow
by Zacks Equity Research
PRPO reports strong third-quarter 2025 results with higher revenue, positive cash flow and improved margins in core divisions.
PRPONegative Net Change
earnings medical
BIAF Stock Dips After Q3 Earnings Reflect Lower Sales and Wider Loss
by Zacks Equity Research
bioAffinity's third-quarter 2025 performance shows lower sales and a wider loss as it pivots to focus on CyPath Lung and expands VA system adoption.
BIAFPositive Net Change
biotechnology biotechs earnings medical
SMID Stock Falls After Reporting Weak Q3 Earnings and Softer Rentals
by Zacks Equity Research
Smith-Midland shares decline as mixed Q3 earnings show stronger product sales but weaker barrier rentals, shaping a cautious outlook for the rest of 2025.
SMIDPositive Net Change
construction earnings
WFCF Stock Dips as Q3 Earnings Highlight Growth Beyond Core Beef
by Zacks Equity Research
WFCF shares fall despite stronger Q3 earnings, as diversified verification services offset continued weakness in beef-related activity.
WFCFNo Net Change
consumer-discretionary earnings
TSS Q3 Earnings & Revenues Fall Y/Y Even As 2026 Outlook Improves
by Zacks Equity Research
TSSI shares plunge after a weak Q3 earnings, but rising AI demand, stronger operations and upbeat guidance suggest growth may accelerate in 2026.
TSSINo Net Change
earnings industrial-products
SYPR's Q3 Earnings Flat Y/Y, Revenues Down Y/Y on Vehicle Market Slowdown
by Zacks Equity Research
Sypris' Q3 earnings remained steady year over year but posted a 19.6% revenue decline, driven by a commercial vehicle downturn. CEO eyes recovery in 2026 amid continued tariff and supply chain pressures.
SYPRNo Net Change
computers earnings tech-stocks
Stratus Swings to Q3 Loss on Weak Sales, One-Time Charges
by Zacks Equity Research
STRS posts a wider year-over-year loss in Q3 amid halted home sales and project impairments, despite stable leasing revenue and a robust cash position.
STRSPositive Net Change
earnings finance
Espey's Q1 Earnings Rise Y/Y on Margin Gains and Navy Contracts
by Zacks Equity Research
ESP's Q1 earnings grow year over year despite lower sales, driven by better margins and progress on Navy-funded projects. Strong backlog supports a positive full-year outlook.
ESPNegative Net Change
aerospace earnings
PDYN Q3 Loss Narrows Y/Y, Leans on Defense Contracts to Drive Growth
by Zacks Equity Research
Palladyne AI incurred a narrower year-over-year loss in Q3, supported by warrant gains, as defense contracts and tech integrations position the company for future growth.
PDYNNegative Net Change
business-services earnings
Ampco-Pittsburgh Stock Gains Post Strong Q3 Earnings and Restructuring
by Zacks Equity Research
AP reports stronger third-quarter 2025 results as ALP hits record EBITDA and facility exits reshape earnings potential.
APNegative Net Change
earnings industrial-products
Applied Energetics Stock Falls as Q3 Revenues Drop and Losses Widen
by Zacks Equity Research
AERG posts sharply lower revenues and wider losses in Q3 as contract funding stalls, pushing the stock lower and pressuring near-term business momentum.
AERGPositive Net Change
earnings tech-stocks
NetSol Technologies Slides After Q1 Loss Despite Revenue Growth
by Zacks Equity Research
NTWK shares drop after a weak Q1. Meanwhile, revenues rise, but margins tighten, with management citing investments, FX pressures and a shifting business model.
NTWKPositive Net Change
earnings tech-stocks
Team's Q3 Earnings Fall Y/Y Despite Strong Revenue Gains
by Zacks Equity Research
TISI shares decline after Q3 earnings results, but rising revenues, stronger margins and improving segment performance highlight ongoing progress in its transformation plan.
TISINegative Net Change
construction earnings